ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.288,28
0,30%
S&P 500
5.453,57
-0,13%
Dow Jones
39.124,16
0,01%
Euro vs US Dollar
1,07307
-0,05%
Bitcoin
62.855,92
0,41%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. SomaLogic Inc (SLGC)

  7. SomaLogic Inc (SLGC) News

SLGC

SomaLogic (SLGC)

SomaLogic Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SLGC
DatumZeitQuelleÜberschriftSymbolFirma
16/01/202414h00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:SLGCSomaLogic Inc
12/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SLGCSomaLogic Inc
12/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SLGCSomaLogic Inc
10/01/202403h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLGCSomaLogic Inc
10/01/202403h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLGCSomaLogic Inc
10/01/202403h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLGCSomaLogic Inc
09/01/202423h16Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SLGCSomaLogic Inc
05/01/202422h43Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SLGCSomaLogic Inc
05/01/202422h41Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SLGCSomaLogic Inc
05/01/202422h40Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SLGCSomaLogic Inc
05/01/202422h39Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SLGCSomaLogic Inc
05/01/202422h38Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SLGCSomaLogic Inc
05/01/202422h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLGCSomaLogic Inc
05/01/202404h23GlobeNewswire Inc.Standard BioTools Stockholders Approve Merger with SomaLogicNASDAQ:SLGCSomaLogic Inc
05/01/202403h44PR Newswire (US)SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special MeetingNASDAQ:SLGCSomaLogic Inc
05/01/202400h57Business WireMadryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special MeetingNASDAQ:SLGCSomaLogic Inc
04/01/202420h23Business WireMadryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
03/01/202414h00Business WireProxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
02/01/202423h05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SLGCSomaLogic Inc
02/01/202423h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLGCSomaLogic Inc
02/01/202414h00PR Newswire (US)SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
30/12/202301h10Business WireMadryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional DisclosuresNASDAQ:SLGCSomaLogic Inc
29/12/202323h30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SLGCSomaLogic Inc
29/12/202323h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLGCSomaLogic Inc
29/12/202322h42PR Newswire (US)Leading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote "FOR" Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
29/12/202322h21Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SLGCSomaLogic Inc
29/12/202322h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLGCSomaLogic Inc
29/12/202314h42PR Newswire (US)SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All StockholdersNASDAQ:SLGCSomaLogic Inc
28/12/202322h16PR Newswire (US)Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioToolsNASDAQ:SLGCSomaLogic Inc
26/12/202323h11Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SLGCSomaLogic Inc
 Showing the most relevant articles for your search:NASDAQ:SLGC

Kürzlich von Ihnen besucht

AMEX
SGT
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten